Corroborating much of the above information with several bioinformatic tools, Shen et al. postulated that GAPDH is not only unsuitable as an internal reference gene for most cancer research, whether by RNA or protein analyses, but also, it may be a promising biomarker of pan-cancer prognosis [49]. This evidence concerns the gene GAPDH and cancer.